Guangzhou Lays Out Biopharma Welcome Mat In Investment Push

Guangzhou is planning to deepen investment in the biopharmaceutical industry and to formulate preferential policies and incentives to encourage tie-ups with multinational pharma firms. The provincial capital aims to develop the industry as a pillar sector that will contribute 15% of its GDP by 2025.